Literature DB >> 2160953

Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro.

M G Cordingley1, P L Callahan, V V Sardana, V M Garsky, R J Colonno.   

Abstract

A series of synthetic peptides representing authentic proteolytic cleavage sites of human rhinovirus type 14 were assayed as substrates for purified 3C protease. Competition cleavage assays were employed to determine the relative specificity constants (Kcat/Km) for substrates with sequences related to the viral 2C-3A cleavage site. Variable length peptides representing the 2C-3A cleavage site were cleaved with comparable efficiency. These studies defined a minimum substrate of 6 amino acids (TLFQ/GP), although retention of the residue at position P5 (ETLFQ/GP) resulted in a better substrate by an order of magnitude. Amino acid substitutions at position P5, P4, P1', or P2' indicated that the identity of the residue at position P5 was not critical, whereas substitutions at position P4, P1' or P2' resulted in substrates with Kcat/Km values varying over 2 orders of magnitude. In contrast to the 2C-3A cleavage site, small peptide derivatives representative of the 3A-3B cleavage site were relatively poor substrates, which suggested that residues flanking the minimum core sequence may influence susceptibility to cleavage. The 3C protease of rhinovirus type 14 was also capable of cleaving peptides representing comparable cleavage sites predicted for coxsackie B virus and poliovirus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160953

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  The use of recombinant fusion proteases in the affinity purification of recombinant proteins.

Authors:  L E Leong
Journal:  Mol Biotechnol       Date:  1999-10       Impact factor: 2.695

2.  Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase.

Authors:  K S Harris; S R Reddigari; M J Nicklin; T Hämmerle; E Wimmer
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Three-stage assembly of the cysteine synthase complex from Escherichia coli.

Authors:  Ting Wang; Thomas S Leyh
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

4.  Functional dissection of N-acetylglutamate synthase (ArgA) of Pseudomonas aeruginosa and restoration of its ancestral N-acetylglutamate kinase activity.

Authors:  Enea Sancho-Vaello; María L Fernández-Murga; Vicente Rubio
Journal:  J Bacteriol       Date:  2012-03-23       Impact factor: 3.490

5.  Atomic Structures of Anthrax Prechannel Bound with Full-Length Lethal and Edema Factors.

Authors:  Kang Zhou; Shiheng Liu; Nathan J Hardenbrook; Yanxiang Cui; Bryan A Krantz; Z Hong Zhou
Journal:  Structure       Date:  2020-06-09       Impact factor: 5.006

6.  Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.

Authors:  W S Blair; B L Semler
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  A highly specific system for efficient enzymatic removal of tags from recombinant proteins.

Authors:  Frank Schäfer; Annette Schäfer; Kerstin Steinert
Journal:  J Biomol Tech       Date:  2002-09

8.  A green fluorescent protein screen for identification of well-expressed membrane proteins from a cohort of extremophilic organisms.

Authors:  Justus Hammon; Dinesh V Palanivelu; Joy Chen; Chintan Patel; Daniel L Minor
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

9.  Using the IPTG-Inducible Pgrac212 Promoter for Overexpression of Human Rhinovirus 3C Protease Fusions in the Cytoplasm of Bacillus subtilis Cells.

Authors:  Vuong Duong Le; Trang Thi Phuong Phan; Tri Minh Nguyen; Luc Brunsveld; Wolfgang Schumann; Hoang Duc Nguyen
Journal:  Curr Microbiol       Date:  2019-10-14       Impact factor: 2.188

10.  3C-like protease of rabbit hemorrhagic disease virus: identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity.

Authors:  C Wirblich; M Sibilia; M B Boniotti; C Rossi; H J Thiel; G Meyers
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.